Log In
BCIQ
Print this Print this
 

Citalopram ODT, citalopram hydrobromide

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionOrally disintegrating tablet (ODT) formulation of citalopram hydrobromide serotonin (5-HT) reuptake inhibitor
Molecular Target Serotonin (5-HT) receptor
Mechanism of ActionSerotonin (5-HT) reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today